Literature DB >> 25378594

Rictor negatively regulates high-affinity receptors for IgE-induced mast cell degranulation.

Daniel Smrz1, Glenn Cruse2, Michael A Beaven3, Arnold Kirshenbaum2, Dean D Metcalfe2, Alasdair M Gilfillan2.   

Abstract

Rictor is a regulatory component of the mammalian target of rapamycin (mTOR) complex 2 (mTORC2). We have previously demonstrated that rictor expression is substantially downregulated in terminally differentiated mast cells as compared with their immature or transformed counterparts. However, it is not known whether rictor and mTORC2 regulate mast cell activation. In this article, we show that mast cell degranulation induced by aggregation of high-affinity receptors for IgE (FcεRI) is negatively regulated by rictor independently of mTOR. We found that inhibition of mTORC2 by the dual mTORC1/mTORC2 inhibitor Torin1 or by downregulation of mTOR by short hairpin RNA had no impact on FcεRI-induced degranulation, whereas downregulation of rictor itself resulted in an increased sensitivity (∼50-fold) of cells to FcεRI aggregation with enhancement of degranulation. This was linked to a similar enhancement in calcium mobilization and cytoskeletal rearrangement attributable to increased phosphorylation of LAT and PLCγ1. In contrast, degranulation and calcium responses elicited by the G protein-coupled receptor ligand, C3a, or by thapsigargin, which induces a receptor-independent calcium signal, was unaffected by rictor knockdown. Overexpression of rictor, in contrast with knockdown, suppressed FcεRI-mediated degranulation. Taken together, these data provide evidence that rictor is a multifunctional signaling regulator that can regulate FcεRI-mediated degranulation independently of mTORC2.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25378594      PMCID: PMC4258480          DOI: 10.4049/jimmunol.1303495

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

1.  A Rictor-Myo1c complex participates in dynamic cortical actin events in 3T3-L1 adipocytes.

Authors:  G Nana Hagan; Yenshou Lin; Mark A Magnuson; Joseph Avruch; Michael P Czech
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

2.  Impact of actin rearrangement and degranulation on the membrane structure of primary mast cells: a combined atomic force and laser scanning confocal microscopy investigation.

Authors:  Zhao Deng; Tiffany Zink; Huan-yuan Chen; Deron Walters; Fu-tong Liu; Gang-yu Liu
Journal:  Biophys J       Date:  2009-02-18       Impact factor: 4.033

3.  Activation and function of the mTORC1 pathway in mast cells.

Authors:  Mi-Sun Kim; Hye Sun Kuehn; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 4.  Regulation of Ca2+ signaling with particular focus on mast cells.

Authors:  Hong-Tao Ma; Michael A Beaven
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

Review 5.  TOR regulation of AGC kinases in yeast and mammals.

Authors:  Estela Jacinto; Anja Lorberg
Journal:  Biochem J       Date:  2008-02-15       Impact factor: 3.857

6.  Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival.

Authors:  Paul C McDonald; Arusha Oloumi; Julia Mills; Iveta Dobreva; Mykola Maidan; Virginia Gray; Elizabeth D Wederell; Marcel B Bally; Leonard J Foster; Shoukat Dedhar
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

Review 7.  The multiple roles of phosphoinositide 3-kinase in mast cell biology.

Authors:  Mi-Sun Kim; Madeleine Rådinger; Alasdair M Gilfillan
Journal:  Trends Immunol       Date:  2008-09-03       Impact factor: 16.687

8.  An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.

Authors:  Carson C Thoreen; Seong A Kang; Jae Won Chang; Qingsong Liu; Jianming Zhang; Yi Gao; Laurie J Reichling; Taebo Sim; David M Sabatini; Nathanael S Gray
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

9.  TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2.

Authors:  Jeremy Copp; Gerard Manning; Tony Hunter
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

10.  mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor.

Authors:  Janine Masri; Andrew Bernath; Jheralyn Martin; Oak D Jo; Raffi Vartanian; Alexander Funk; Joseph Gera
Journal:  Cancer Res       Date:  2007-12-15       Impact factor: 12.701

View more
  5 in total

1.  Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration.

Authors:  Jordi Creus-Muncunill; Laura Rué; Rafael Alcalá-Vida; Raquel Badillos-Rodríguez; Joan Romaní-Aumedes; Sonia Marco; Jordi Alberch; Isabel Perez-Otaño; Cristina Malagelada; Esther Pérez-Navarro
Journal:  Mol Neurobiol       Date:  2018-02-19       Impact factor: 5.590

Review 2.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

Review 3.  Regulation of innate immune cell function by mTOR.

Authors:  Thomas Weichhart; Markus Hengstschläger; Monika Linke
Journal:  Nat Rev Immunol       Date:  2015-10       Impact factor: 53.106

Review 4.  Ras, PI3K and mTORC2 - three's a crowd?

Authors:  Stephen F Smith; Shannon E Collins; Pascale G Charest
Journal:  J Cell Sci       Date:  2020-10-08       Impact factor: 5.285

Review 5.  Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors.

Authors:  Katerina Kalkusova; Sindija Smite; Elea Darras; Pavla Taborska; Dmitry Stakheev; Luca Vannucci; Jirina Bartunkova; Daniel Smrz
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.